Number of qualified patients: CDEC mentioned the uncertainty in the volume of sufferers with reasonably critical to critical hemophilia B in Canada qualified for etranacogene dezaparvovec. Medical experts consulted by CADTH indicated that some people who are categorised as owning delicate or average disorder might have a critical bleeding phenotype, https://cesarxzdfe.pages10.com/not-known-factual-statements-about-hemgenix-71318515